Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01104129 · ClinicalTrials.gov registry record

Stool Testing for Pancreatic Cancer

A clinical trial, sponsored by Columbia University.

Completed
Registry status
158
Enrollment target

NCT01104129 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 158 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01104129 has completed, sponsored by Columbia University.

COMPLETED
Registry status
158 participants
Enrollment target

Study Summary

The purpose of this study is to determine if pancreatic cancer/pre-cancer can be detected in early stages through the molecular analysis of stool samples. Investigators hypothesize that analysis of stool samples using digital melt curve (DMC) analysis, can be used as a sensitive and specific method to detect the common genetic abnormalities present in pancreatic cancers and pre-cancerous lesions of the pancreas.

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2009-07-09
Est. Completion 2016-11-29

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT01104129

The ClinicalTrials.gov registry entry for NCT01104129 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01104129 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01104129 about?

NCT01104129 is a clinical study titled "Stool Testing for Pancreatic Cancer". The purpose of this study is to determine if pancreatic cancer/pre-cancer can be detected in early stages through the molecular analysis of stool samples. Investigators hypothesize that analysis of stool samples using digital melt curve (DMC) analysis, can be used as a sensitive and specific method ...

What is the current status of trial NCT01104129?

This trial is currently completed. The enrollment target is 158 participants. The study started on 2009-07-09. Estimated completion is 2016-11-29.

Who is sponsoring clinical trial NCT01104129?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.